- Open Access
Caspase-11, a specific sensor for intracellular lipopolysaccharide recognition, mediates the non-canonical inflammatory pathway of pyroptosis
Cell & Biosciencevolume 9, Article number: 31 (2019)
Pyroptosis, a type of programmed cell death that along with inflammation, is mainly regulated by two main pathways, cysteinyl aspartate specific proteinase (caspase)-1-induced canonical inflammatory pathway and caspase-11-induced non-canonical inflammatory pathway. The non-canonical inflammatory pathway-induced pyroptosis is a unique immune response in response to gram-negative (G−) bacteria. It is induced by lipopolysaccharide (LPS) on the surface of G− bacteria. This activates caspase-11 which, in turn, activates a series of downstream proteins eventually forming protein pores on the cell membrane and inducing cell sacrificial processes. Caspase-11 belongs to the caspase family and is an homologous protein of caspase-1. It has the ability to specifically hydrolyze proteins, but it is still unclear how it regulates cell death caused by non-canonical inflammatory pathways. The present study describes a pathway that enables LPS to directly enter the cell and activate caspase-11, and the key role caspase-11 plays in the activation of pyroptosis and inflammation.
Programmed cell death is an orderly phenomenon of cellular self-destruction. It is vital for the development of the organism, metamorphosis, tissue homeostasis and pathogenesis and triggered by both intrinsic and extrinsic factors. Programmed cell death, serves to remove unneeded or potentially harmful cells from the body . At the end of the last century, there were two types of programmed cell death: apoptosis and necroptosis, a programmed form of necrosis . With advances in science and technology, researchers have discovered another process of programmed cell death that is different from apoptosis or necroptosis, namely pyroptosis , which occupies an important role as an inflammatory form of programmed cell death in host immunity and essential for controlling microbial pathogens infections. In pyroptosis, caspase-1 is activated and mediates cell death through the processing and release of pro-inflammatory cytokines, interleukin-1β (IL-1β) and IL-18 by rapid rupture of the cell plasma membrane. This inflammatory response is fatal and results in cell death [4, 5]. Two gene pathways, cysteinyl aspartate specific proteinase (caspase)-1 induced canonical inflammatory pathway and caspase-11 induced non-canonical inflammatory pathway, have been suggested to regulate pyroptosis . The canonical inflammatory pathway is stimulated by a range of microbial infections and non-infectious stimuli , whereas the non-canonical inflammatory pathway is activated by intracellular LPS derived from gram-negative (G−) bacteria . However, most studies have focused on the validation of the canonical inflammatory pathway and there are limited comprehensive reviews of the regulation of non-canonical inflammatory pathways [9, 10]. This review aims to summarize the current research on non-canonical inflammatory pathways, elaborate on the mechanism, and summarize the similarities and differences between the two pathways.
Discovery of pyroptosis
In 1972, Kerr and colleagues observed that ‘shrinkage necrosis’ had a regulatory role in the morphological patterns of cell death in animal cell populations. They renamed this processed apoptosis [11, 12]. Apoptosis involves condensation of the nucleus and cytoplasm, cellular fragmentation into membrane bound protuberances which form on the cell surface. In 1988, Laster discovered a phenomenon of fragmentation of cell membranes and release of contents in the different types of cells induced by tumor necrosis factor (TNF)-α in the process of necrosis . Since then, many studies have found gene regulatory networks in these so-called ‘necrosis’. In 2005, Degterev proposed the concept of “necroptosis” as distinct from conventional necrosis , which was mainly characterized by cell swelling and roundness, cell organelle expansion and cell membrane distension and rupture . When the cell membrane was broken, the cytoplasm would release its contents, which contains proinflammatory cytokines, into the extracellular space and would trigger an inflammatory response .
Early in 1996, a different process of cell death was emerging. Chen et al. microinjected Shigella flexneri into macrophages and observed that S. flexneri triggered macrophage death. They classified this death as apoptosis because they observed typical morphological changes of apoptosis in the cell including, cell rounding, shrinkage, blebbing and lysis during death . Furthermore, Hilbi found that S. flexneri bound directly to caspase-1 during the process. The invasion plasmid antigen B (ipaB) present in the cytoplasm bunds to caspase-1 [interleukin 1-β (IL-1β) converting enzyme], leading to its activation [18, 19]. Caspase-1 activity is pivotal for the induction of Shigella-induced macrophage apoptosis. Hersh et al. also observed caspase-mediated ‘apoptosis’ of macrophages in 1999, following microinjection with the secreted protein SipB from Salmonella spp. However, caspase-1 knockout macrophages were not susceptible to Salmonella-induced cytotoxicity . Both Chen and Hersh observed that this so-called “apoptosis” would promote secretion of IL-1β which not only initiates the process of inflammation, but also cell death which similar to necrosis [17, 20].
It was not until 2001, when Brennan used the term ‘Pyroptosis’ to describe this combination of apoptosis and necrosis . “Pyro” in Greek means fire, and “Ptosis” means falling, reflecting the fact that the essence of cell death is accompanied by inflammation. Pyroptosis remains a highly conserved process that might exist in all vertebrates as a mechanism to resist pathogens and promote the immune system. Studies have provided evidence for pyroptosis in terrestrial animals, for example, mice (Mus musculus), humans (Homo sapiens) [22, 23], and also in aquatic species, such as, large webbed bombina (Bombina maxima) , sea bream (Sparus aurata) , Atlantic salmon (Salmo salar) , and zebrafish (Danio rerio) [27, 28].
Morphological changes of pyroptosis
Pyroptosis is a form of cell death which occurs in phagocytes (macrophages, monocytes, and dendritic cells (DCs)) , and comprises mainly of two stages: early and late. In the early stage, a large number of vesicles are produced on the cell membrane, called pyroptotic bodies . The shape and size of pyroptotic bodies are similar to apoptotic bodies. In the late stage, a large number of pores (10–14 nm in diameter) appear on the cell membrane and induce the rupture of the cell membrane (Fig. 1) . Moreover, intracellular substances such as IL-1β, IL-18, and lactate dehydrogenase are released through the pores, resulting in an inflammatory response surrounding the dead cells . It is difficult to separate pyroptosis from apoptosis and necroptosis by morphological changes, as only small distinctions are apparent in histomorphology. The greatest similarity between pyroptosis and apoptosis is the production of pyroptotic and apoptotic bodies. The greatest similarity between pyroptosis and necroptosis is the release of cytoplasmic content and proinflammatory factors. In contrast, apoptosis does not result in inflammation, and necroptosis does not result in the formation of vesicles. Indeed, apoptosis appears more like an aging process, with the increase of intracytoplasmic garbage, fragmentation of nuclear material, atrophy of cells, and the eventual formation of apoptotic bodies which are exfoliated or engulfed by surrounding cells (Fig. 1). In addition, necroptosis can be compared to a bursting balloon, where cell death is initiated by receptors such as tumour necrosis factor receptor 1 which requires receptor-interacting protein 1 (RIP1) (also known as RIPK1) and RIP3 (also known as RIPK3), resulting in cell detachment, swelling, disintegration of mitochondrial, lysosomal and plasma membranes and the ultimate lysing of the cell . The cytoplasm of the dead cells, including the organelles is released (Fig. 1). In comparison, pyroptosis is more comparable to a filter, which produces a large number of holes (pyroptotic body) on the surface of the cell membrane, resulting in the release of a large number of small cellular components (proinflammatory cytokines) into the cytoplasm, while cellular components larger than the holes (macromolecular proteins, organelles) are left inside (Fig. 1) .
How to accomplish pyroptosis through caspase-1 induced canonical inflammatory pathway
Caspase-1-activating platforms called “inflammasomes”, which are multi-protein signaling complexes that assemble in response to detection of cellular disruption and noxious stimuli such as bacterial, viral and host molecules, toxins, pollutants, crystals, UV radiation etc, and initiate inflammatory immune responses. The formation of the inflammasomes marks that caspase-1 will be activated, triggers a series of cascade reactions and accomplish pyroptosis.
Currently, the known inflammasome receptors include three gene families: Nod-like receptors (NLRs) , AIM2-like receptors (ALRs) , and the tripartite motif family (TRIM) of which only pyrin is an inflammasome . In addition, the adaptor protein-ASC (apoptosis-associated speck-like protein) is expressed in epithelial tissues and immune cells such as neutrophils and macrophages and consists of two death-fold domains: one pyrin domain (PYD) and one caspase activation and recruitment domain (CARD) . While the exact composition of the inflammasome is dependent on the initiating compound [37, 38] both the receptor family and the ASC are critical components of the inflammasome that are involved in the recruitment and activation of the caspase-1 precursor, procaspase-1 [39, 40].
In the initial process of pyroptosis the inflammasome activates caspase-1 through a Nod-like receptor (NLRP1, 3, 6, 7, 12, NLRC4), AIM2, or pyrin, all of which contain a CARD or pyrin domain (PYD) [41, 42]. The CARD domain is able to recruit and bind procaspase-1 through the CARD–CARD and PYD–PYD interactions [36, 43]. The recruitment of procaspase-1 into the ASC via the CARD–CARD interactions which results in its cleavage into its N-terminal pro-domain and C-terminal catalytic and interaction domains; all caspases contain two essential caspase catalytic domains: the p10 subunit and the p20 subunit, the latter containing the key catalytic residues cysteine and histidine. These two cleaved C-catalytic domains integrate with each other and formed mature/activated caspase-1 (Fig. 2) .
The mature/activated caspase-1 induces the formation of the pores in the cell membranes, on the other it could mature the intracellular inflammatory cytokines and assist in ecliciting the inflammatory response. During this process, caspase-1 has been shown to hydrolyze another protein named Gasdermin (GSDM) D in mouse and human cells. GSDM D belongs to the Gasdermin family that includes GSDM A, B, C, D, E, and DFNB59 . Also, GSDM D is a protein mainly expressed in immune cells  and was discovered to form a pore and act as the effector for pyroptosis . The GSDM D protein polypeptide chain consists of a total of approximately 480 amino acids and has two major domains: the N-terminal pore-forming domain (PFD) and the C-terminal repressor domain (RD) which are linked by a linker loop . The PFD plays a crucial role in the formation of pyroptosis, and the main function of the RD is to inhibit the activity of the GSDMD-N domain in normal cells (Fig. 2) .
When caspase-1 binds to GSDM D, it will cleave the linker loop between PFD and RD, and the cleaved site is located in D276↓G277. Cleaved proteins result in the separation of two domains, and PFD will play an important role in the following process (Fig. 2). Ding et al.  found that PFD appeared as oligomers and generate an oligomeric ring after cleaved, which diameters in 10–14 nm. Robin extracted the ring and determine the protein size of about ~ 720 kDa on a blue native-page gel . Based on the results, we speculate that 24 PFDs can be aggregated to form a protein pore. The resulting pores appear on the cell membrane, resulting in changes in membrane permeability, like membrane breakage. The remaining question is how the pores appear on the cell membrane?
Polyprotein pore has the greatest affinity for lipid species . Rogers et al. generated a model of DFNA5 (GSDM E, homology to GSDM D) and conjecture that the interior of the multimeric protein harbours a membrane targeting motif, relies on this motif, which locates the multimeric protein at the cell membrane, resulting in numerous small pores in the cell membrane [49, 50]. Eventually, substances smaller than the pores, such as Na+, water, cytoplasmic proteins, and proinflammatory factors, will flow out of the pores, while larger organelles, such as ribosomes, will be blocked in the cells. Eventually, the cells die and a series of inflammatory reactions are initiated around the cells  (Fig. 2).
Whether the caspase-1-mediated pathway is the only channel that regulates pyroptosis?
The caspase-1 mediated pathway has been considered to be the only pathway to mediate pyroptosis for many years. In 2011, Kayagaki observed that caspase-11 is critical for IL-1β production and pyroptosis in macrophages infected with Escherichia coli, Citrobacter rodentium and Vibrio cholerae, which revealed a different regulatory pathway for pyroptosis . However, it spent a long time from the identification of caspase-11 to verify its unique pathway. In the mid-1990s, scholars succeeded in cultivating knockout caspase-1 (CASP1−/−) and caspase-11 (CASP11−/−) mice. Li et al.  found that CASP1−/− mice were resistant to endotoxic shock induced by LPS, and Wang et al.  reported the same resistance in CASP11−/− mice. During the development of CASP1−/− and CASP11−/− mice, it was observed that mutant mice were resistant to LPS infection, while wild-type mice developed significant lethal sepsis. Due to the similarity of the results of these studies, the current belief at that time and for the next decade was that these two genes were closely related to inflammation and played a role in regulating the same pathway.
Later studies have however since revealed that caspase-1 and caspase-11 play different roles in the inflammatory response . In 2011, Kayagaki et al. observed that CASP11−/− mice exhibited defects in IL-1β production in response to E. coli, C. rodentium or V. cholerae, but secreted IL-1β normally in response to monosodium urate and adenosine triphosphate (ATP). Based on this result, these authors speculated that caspase-11 mediated an unusual proinflammatory pathway. Their study demonstrated a loss of caspase-11 rather than caspase-1 protected mice following a lethal dose of LPS, and that caspase-11 does not require NLRP3 and ASC in processing cell death. These data highlight a unique proinflammatory role for caspase-11 to clinically significant bacterial infections. In addition, the authors suspected that the pathway was induced by LPS specific stimulation to induce cell death . More studies have also shown that the caspase-11-mediated pyroptosis has strong specificity for LPS. G− bacteria such as V. cholerae, ΔFlag Salmonella, E. coli, enterohaemorrhagic E. coli, Legionella pneumophila, C. rodentium could all induce activation of the caspase-11 in macrophages [55, 56], but G+ bacteria did not demonstrate similar results . In addition, LPS-mutant E. coli failed to activate caspase-11 . Since then, the caspase-11-mediated pathway in pyroptosis has been named as the non-canonical inflammatory pathway to highlight its specific ability to recognize the LPS on G− bacteria surface.
Relationship between caspase-1 and caspase-11
In 1996, Chen  reported an enzyme that has the ability to activate proIL-1β and proIL-18 which they named IL-1β converting enzyme (ICE). However, subsequent studies found the greater significance of ICE is to “awaken” and “execute” cell death [53, 57, 58]. IL-1β converting enzyme and similar proteins were established as a new group, caspase family, and ICE was renamed caspase-1. The caspase family consists of 15 homologous proteins, and has certain species specificity . According to phylogenetic analysis, the caspase family can be divided into an apoptosis subfamily represented by caspase-3 and an inflammatory subfamily represented by caspase-1 (Fig. 3).
Caspase-1 and caspase-4, -5/-11 belong to the proinflammatory caspase subfamily, and their highly homologous sequences imply their functional similarity . Caspase-11 has been cloned and identified in mice  and caspase-4/-5 has been identified in humans, both of which have showed up to 60% homology in amino acid sequence [61, 62] (Fig. 3). In addition, Shi et al.  demonstrated that caspase-4/-5 functionally similar to murine caspase-11 could induce human monocytes, epithelial cells, and keratinocytes pyroptosis. The similarity between caspase-1 and caspase-11 (-4, -5) may be the reason why they can play a similar role in pyroptosis, however, the heterogeneity between the sequences of caspase-1 and caspase-11 may be responsible for their mediation of two different pathways [64, 65].
The different structure of caspase-11 and caspase-1 indicates different function
The caspase-11 cDNA has a full length of 1350 bp and contains an open reading frame (ORF) encoding 373 amino acids. The initiation codon is located at 35–37 nucleotides and the stop codon is located at 1154–1156 nucleotides of the cDNA sequence . There are 39 Poly (A) signals (AATAAA) at the end of the non-coding region of the cDNA, and the predicted molecular weight of the encoded caspase-11 protein is 43 kDa. As with caspase-1, caspase-11 is composed of an N-terminal CARD domain and a C-terminal caspase catalytic (subunit p20 + p10) domain. In addition, between each domain, there is a conserved hydrolysis site. In caspase-1, cleavage between the subunit p20 and subunit p10 is dependent on the aspartate residue (Asp−). Similarly, the protein structure of caspase-11 was predicted and it was found that the cleavage site of p20 and p10 subunit is similar to caspase-1 and highly conserved . Moreover, the main catalytic sites of caspase-1 are His237, Gly238 of p20 subunit, and Cys285 of p10 subunit, which is conserved in caspase-11 (His206, Gly207 and Cys254) [66, 67]. In addition, the partial sequence of the P1 pocket of caspase-1 where the catalytic site is located (Arg179, Gln283, Arg341, and Ser347) is also conserved in caspase-11 (Arg148, Gln252, Arg310, and Ser316) (Fig. 4). The results demonstrate that the function of caspase-11 may be the same as that of caspase-1, both of which perform enzymolysis through its P1 active group and choose the Asp site of the substrate for enzymolysis.
However, some functional loci may be responsible for their functional differences. Compared to caspase-1, the hydrolysis site between p20 and CARD is not conserved in caspase-11 [66,67,68]. In caspase-1, the cleavage between the p20 and p10 subunits is dependent on the Asp− at the p10 position. However, there are two adjacent Asp- residues (Asp59 and Asp80) in caspase-11, which may be potential hydrolysis sites at the N-terminus when processing p20, and procaspase-11 is hydrolyzed here to produce a 20 k Da subunit. In addition, the sites that constitute P2–P4 pocket in caspase-1 (Val338, Trp340, His342, Pro343, Arg383, and Gln385) are different in caspase-11 (Leu307, Tyr309, Asp311, Lys312, and His352), only Gln354 is conserved with caspase-1 . The P2–P4 pocket is the binding group of caspase-11, suggesting that the difference in the substrates used may be the main reason for mediating the two different pathways (Fig. 4).
How does caspase-11 regulate non-canonical inflammatory pathways?
While the signaling pathways and molecular mechanisms of non-canonical inflammatory pathways need to be further characterized, an almost complete pathway has been described in the present study. The activation of the canonical inflammatory pathway often requires the formation of inflammasomes, although Kayagaki et al.  found that caspase-11 does not seem to require NLRP3 and ASC to induce pyroptosis formation, suggesting that the caspase-11-mediated non-canonical inflammatory pathway may complete the death process through another mechanism. Researchers have demonstrated there are two stages of non-canonical inflammatory pathways, initiation and excitation . In the initial stages, G− bacteria activate the transcriptional expression of intracellular genes, generating a large amount of procaspase-11 and inflammation-related inflammatory cytokines. Once procaspase-11 is synthesized, non-canonical inflammasome is activated by cytosolic recognition of intracellular LPS derived from bacteria that have escaped phagolysosomes, and trigger the cell death. This pathway is independent of Toll-like receptor 4 (TLR4), the well-known extracellular receptor for LPS, but instead depends on the inflammatory protease, caspase-11.
The process of producing procaspase-11 and other inflammatory factors
When G− bacteria invade the body, the immune system is activated, and the initial stages of pyroptosis activate. Innate immune cells, especially macrophages, can rapidly recognize the evolutionarily conserved structures on pathogens, pathogen-associated molecular patterns (PAMPs) of invading pathogens through a limited number of pattern recognition receptors (PRRs), such as scavenger receptors and the family of Toll-like receptors (TLRs) which have been studied most extensively. Pattern recognition receptors present at the cell surface or intracellularly signal the presence of infection and elicit proinflammatory and antimicrobial responses by activating a intracellular signaling pathways, including adaptor molecules, kinases, and transcription factors . PRR-induced signal transduction pathways ultimately result in the transcription and translation of genes, including caspase-11 and IL-1β, for the non-canonical inflammatory response, including NLRP3, caspase-1 and IL-18 [71, 72].
Is there a mechanism to expand and accelerate the production of procaspase-11 or other proinflammatory factors? Recent studies show that most of the genes in pyroptosis are constitutively expressed. For example, during the transcription of caspase-11, the 5′-terminal of the caspase-11 contains multiple NF-κB binding sites and a STAT binding site. TLR receptors or IFNs sequentially activate NF-κB and STAT transcription, and a large amount of procaspase-11 is produced during the progress. In addition, TLR receptors or IFNs cascade amplify the expression of these inflammatory genes. For example, TLR 2 promotes the expression of caspase-11 by activating the NF-κB-transduction of the Myd88 [8, 73]. TLR 3 also promotes the expression of caspase-11 by inducing the production of IFN-α/β (IFN-I) . After transcription and translation, a large amount of procaspase-11 and proIL-1β, proIL-18 were generated and distributed in the cytoplasm (Fig. 5).
Non-canonical inflammasome formation and procaspase-11 maturation
Under certain conditions, inflammation is induced by a canonical inflammatory pathway and recognized and activated by cell membrane surface receptors like TLR 4 . In contrast, non-canonical inflammasomes, i.e. the complex of procaspase-11 and LPS, are activated in cells. LPS can activate the transcription of caspase-11 through TLR or other receptors. So, does LPS also cleave and generate mature caspase-11 by signal transduction of a cell surface receptor? Recent studies have discovered that the host is capable of TLR4-independent recognition of LPS in the cytosol . In addition, Shi et al. found that not only murine caspase-11 but also human caspase-4 and -5 do not employ an upstream signaling cascade to detect LPS, but instead sense LPS directly . LPS binds with procaspase-11, initiate procaspase-11 oligomerization and form mature/activated caspase-11. However, binding-deficient CARD-domain point mutants in procaspase-11 did not respond to LPS with oligomerization or activation and failed to induce pyroptosis upon LPS electroporation or bacterial infections, indicating that the binding site of LPS is located on the CARD domain of procaspase-11 . So, how does LPS enter the cell to bind to procaspase-11?
Vanaja et al.  reveal a fundamental mechanism that delivers LPS into the cytosol to alert the immune system. Outer membrane vesicles (OMVs) are a naturally secreted product of G− bacteria, and LPS is one of the most abundant components of OMVs . The recent study showed that the size, shape and membrane composition of OMVs are similar to that of extracellular vesicles formed by eukaryotic cells , and Vanaja and colleagues  found OMVs secreted by G− bacteria function as a vehicle to deliver LPS into the cytosol from early endocytic compartments and lead to pyroptosis. However, Etienne et al.  found that host cells could consume G− bacteria through pathogen-containing vacuoles (PCVs) formed by eukaryotic cell membrane, suggesting that LPS may enter the cytoplasm through multiple pathways.
The next step is to understand how the host cells detect the swallowed vesicles. There are 11 genes encoding guanylate binding protein (Gbp) in murine cells, and GBPchr3 (GBP encoded on chromosome 3) plays an important role in the lysis of the vacuoles of G− bacteria . Initially, Pilla et al.  discovered that Gbpchr3 play a role in the detection of cytoplasmic LPS and the subsequent activation of the noncanonical inflammasome leading to pyroptosis. Another study observed large amounts of GBPchr3 attached on the vesicle membrane, resulting in the vesicle lysis, and eventually, the bacteria released into the cytoplasm (Fig. 5) . In addition, a process negatively regulated by a subclass of IRG proteins called IRGMs may play an important role in the recognition of non-self vesicles by GBP. The paralogous IRGM proteins Irgm1 and Irgm3 fail to robustly associate with non-self PCVs but instead reside on self organelles including lipid droplets (LDs). Whereas IRGM-positive LDs are guarded against the stable association with GBPs . Furthermore, Gbp1 and Gbp2 could successful localize to IRGM−/− LDs, and IRGM−/− LDs further be delivered to autophagosomes for degradation, which evident that IRGM proteins act as ‘‘guards’’ that prevent lysis of non-self vesicles .
Cierra et al. discovered that TRIF-dependent type I Interferon (IFN-I) and its related pathway is necessary for the activation of caspase-11. When LPS enters into the macrophages the cells modulate IFN-I signaling-induced gene expression to assist procaspase-11 to recognize the intracellular LPS, and ultimately activate caspase-11 . Since then, the CARD domain of caspase-11 interacts with LPS to form the procaspase-11-LPS complex, also known as non-canonical inflammasome . Procaspase-11 is cleaved and activated as caspase-11 in the non-canonical inflammasome.
Caspase-11 mediated proinflammatory response
The most important feature of pyroptosis is the release of proinflammatory cytokines from cells and the induction of inflammation. In canonical inflammatory pathways, caspase-1 could directly cleave proIL-1β and proIL-18 and produce mature/activated IL-1β and IL-18. However, Kayagaki found that CASP11−/− macrophages did not affect the maturation of IL-1β and IL-18 following G− bacterial injection, while the mature IL-1β and IL-18 in CASP1−/−/CASP11−/− macrophages were significantly reduced. At the same time, the expression of caspase-1 was observed in G− bacteria-injected macrophages. These results indicate that caspase-11 itself may not have the ability to cleave proIL-1β and proIL-18 and that maturation still requires the help of caspase-1 (Fig. 5) [8, 52]. Kayagaki  then discovered that caspase-11 needs to induce NLRP3 activation through an unknown pathway to promote the activation of procaspase-1, and that activated caspase-1, in turn, induces the activation and maturation of proIL-1β and proIL-18 (Fig. 5).
Recent studies have found that GSDM D plays an important role in both the caspase-1 mediated canonical inflammatory pathway and the caspase-11 mediated non-canonical inflammatory pathway [50, 83]. When caspase-11 is activated, it induces the downstream substrate GSDM D to cleave into the N terminal and C terminal domains, with the N terminal domain on the cell membrane. Cleavage removes the C-terminal fragment (GSDMD-CT). The N-terminal oligomerizes in membranes to form pores that triggers pyroptosis . With caspase-1 cleaving the interleukin precursor (proIL)-1β and proIL-18 in the cell and releasing mature/activated IL-1β and IL-18. Mature/activated IL-1β and IL-18 along with other cytoplasmic components are released from the pores (Fig. 5) . The release of these proinflammatory factors would further lead to cellular inflammation.
Compared with G+ bacteria, G− bacteria have a layer of LPS on the cell wall, which is also called “endotoxin”. The presence of endotoxins in the blood is called endotoxemia, which leads to septic shock . Moreover, LPS is thought to cause autoimmune-based host responses, such as multiple sclerosis . Non-canonical inflammatory pathways of pyroptosis play an important role in inhibiting the proliferation of G− bacteria and scavenging bacteria, and could effectively prevent the massive deposition of LPS. Therefore, the exploitation of drugs that stimulate the expression of caspase-11 and activate non-canonical inflammatory pathways will be beneficial for the treatment of a large number of bacterial diseases.
In this paper, we summarize the current research of non-canonical inflammatory pathways-induced pyroptosis, which is related to the host cell response to G− bacteria. By carefully studying the molecular processes that occur in cells in non-classical inflammatory pathways and paying attention to the results of pyroptosis that affect the development of inflammation and immune responses, we will better characterize new pathways of cell death and further understand the interactions between host and G− bacteria. However, there is still gaps in the knowledge on the study of non-canonical inflammatory pathways. First, the non-canonical inflammatory pathways are only studied in humans and mice, and it is unclear whether other species have the same mechanism. For example, do zebrafish recognize intracellular LPS by NOD1 instead of caspase-11 (-4,-5) homologs ? In addition, the mechanism of non-canonical inflammatory pathways is not complete, and questions exist as to whether OMVs and PCVs coexist? What is the inhibition mechanism of caspase-11 (only few studies indicated that NleF and could inhibit caspase-11 activation [88, 89])? The study of non-canonical inflammatory pathways must be a process full of exploration of the unknown.
cysteinyl aspartate-specific proteinase
- G− :
- G+ :
IL-1β converting enzyme
- CASP−/− :
knocked out caspase
- Asp− :
aspartic acid residue
pattern recognition receptors
triplet motif family
NLR family pyrin domain containing 3
Nuclear factor-kappa B complex subunits
signal transducers and activators of transcription
myeloid differentiation factor 88
GBP encoded on chromosome 3
caspase recruitment domain-containing
- GSDM D:
- DFNA 5:
Assuncao GC, Linden R. Programmed cell deaths. Apoptosis and alternative deathstyles. Eur J Biochem. 2004;271(9):1638–50.
Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. 2005;73(4):1907–16.
Sendler M, Mayerle J, Lerch MM. Necrosis, apoptosis, necroptosis, pyroptosis: it matters how acinar cells die during pancreatitis. Cell Mol Gastroenterol Hepatol. 2016;2(4):407–8.
Jorgensen I, Miao EA. Pyroptotic cell death defends against intracellular pathogens. Immunol Rev. 2015;265(1):130–42.
Shi J, Gao W, Feng S. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2016;42(4):245–54.
Crowley SM, Vallance BA, Knodler LA. Noncanonical inflammasomes: antimicrobial defense that does not play by the rules. Cell Microbiol. 2017;19(4):1–9.
Frantz S, Ducharme A, Sawyer D, Rohde LE, Kobzik L, Fukazawa R, et al. Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction. J Mol Cell Cardiol. 2003;35(6):685–94.
Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science. 2013;341(6151):1246–9.
Rathinam VAK, Fitzgerald KA. Inflammasome complexes: emerging mechanisms and effector functions. Cell. 2016;165(4):792–800.
Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157(5):1013–22.
Kerr JFR. A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes. J Pathol. 1965;90(2):419–35.
Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239–57.
Laster SM, Wood JG, Gooding LR. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol. 1988;141(8):2629–34.
Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1(2):112–9.
Nazzal D, Cantéro A-V, Therville N, Ségui B, Nègre-Salvayre A, Thomsen M, et al. Chlamydia pneumoniae alters mildly oxidized low-density lipoprotein-induced cell death in human endothelial cells, leading to necrosis rather than apoptosis. J Infect Dis. 2006;193(1):136–45.
Berghe TV, Vanlangenakker N, Parthoens E, Deckers W, Devos M, Festjens N, et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ. 2010;17(6):922–30.
Chen Y, Smith MR, Thirumalai K, Zychlinsky A. A bacterial invasin induces macrophage apoptosis by binding directly to ICE. EMBO J. 1996;15(15):3853–60.
Hilbi H, Chen Y, Thirumalai K, Zychlinsky A. The interleukin 1beta-converting enzyme, caspase 1, is activated during Shigella flexneri-induced apoptosis in human monocyte-derived macrophages. Infect Immun. 1997;65(12):5165–70.
Hilbi H, Moss JE, Hersh D, Chen Y, Arondel J, Banerjee S, et al. Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J Biol Chem. 1998;273(49):32895–900.
Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci USA. 1999;96(5):2396–401.
Cookson BT, Brennan MA. Pro-inflammatory programmed cell death. Trends Microbiol. 2001;9(3):113–4.
Lachner J, Mlitz V, Tschachler E, Eckhart L. Epidermal cornification is preceded by the expression of a keratinocyte-specific set of pyroptosis-related genes. Sci Rep. 2017;7(1):1–11.
Ritter JL, Genco CA. Neisseria gonorrhoeae—induced inflammatory pyroptosis in human macrophages is dependent on intracellular Gonococci and Lipooligosaccharide. J Cell Death. 2018;11:1–11.
Xiang Y, Yan C, Guo X, Zhou K, Li S, Gao Q, et al. Host-derived, pore-forming toxin-like protein and trefoil factor complex protects the host against microbial infection. Proc Natl Acad Sci USA. 2014;111(18):6702–7.
Angosto D, Lópezcastejón G, Lópezmuñoz A, Sepulcre MP, Arizcun M, Meseguer J, et al. Evolution of inflammasome functions in vertebrates: inflammasome and caspase-1 trigger fish macrophage cell death but are dispensable for the processing of IL-1β. Innate Immun. 2012;18(6):815–24.
Pontigo JP, Agüero MJ, Sánchez P, Oyarzún R, Vargaslagos C, Mancilla J, et al. Identification and expressional analysis of NLRC5 inflammasome gene in smolting Atlantic salmon (Salmo salar). Fish Shellfish Immunol. 2016;58:259–65.
Varela M, Romero A, Dios S, Vaart MVD, Figueras A, Meijer AH, et al. Cellular visualization of macrophage pyroptosis and interleukin-1β release in a viral hemorrhagic infection in zebrafish larvae. J Virol. 2014;88(20):12026–40.
Vincent WJ, Freisinger CM, Lam PY, Huttenlocher A, Sauer JD. Macrophages mediate flagellin induced inflammasome activation and host defense in zebrafish. Cell Microbiol. 2016;18(4):591–604.
Zhang Y, Xin C, Gueydan C, Han J. Plasma membrane changes during programmed cell deaths. Cell Res. 2017;28(1):9–21.
Chen X, He WT, Hu L, Li J, Fang Y, Wang X, et al. Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res. 2016;26(9):1007–20.
Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol. 2012;28(28):138–61.
Vandenabeele P, Galluzzi LBT, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol. 2010;11(10):700–14.
Agostini L, Martinon F, Burns K, Mcdermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20(3):319–25.
Brunette RL, Young JM, Whitley DG, Brodsky IE, Malik HS, Stetson DB. Extensive evolutionary and functional diversity among mammalian AIM2-like receptors. J Exp Med. 2012;209(11):1969–83.
Xu H, Yang J, Gao W, Li L, Li P, Zhang L, et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature. 2014;513(7517):237–41.
Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13(6):397–411.
Muruve DA, Virginie P, Zaiss AK, Clark SA, Ross PJ, Parks RJ, et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature. 2008;452(7183):103–7.
Yvonne D, Mark P, Sarah K, Claudia K, Christine GS, David A, et al. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med. 2011;3(82):1–9.
Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007;14(1):10–22.
Martin K, Andreas R, Sabine W, Hans-Dietmar B. Active caspase-1 is a regulator of unconventional protein secretion. Cell. 2008;132(5):818–31.
Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, et al. Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity. 2011;34(5):755–68.
Moltke JV, Ayres JS, Kofoed EM, Chavarríasmith J, Vance RE. Recognition of bacteria by inflammasomes. Annu Rev Immunol. 2013;31(31):73–106.
Sandstrom A, Vance RE. Defusing inflammasomes. J Exp Med. 2018;215(3):723–4.
Park HH. Structural features of caspase-activating complexes. Int J Mol Sci. 2012;13(4):4807–18.
Kovacs SB, Miao EA. Gasdermins: effectors of pyroptosis. Trends Cell Biol. 2017;27(9):673–84.
Man SM, Kanneganti TD. Gasdermin D: the long-awaited executioner of pyroptosis. Cell Res. 2015;25(11):1183–4.
Ding J, Wang K, Wang L, Yang S, Qi S, Shi J, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535(7610):111–6.
Aglietti RA, Estevez A, Gupta A, Ramirez MG, Liu PS, Kayagaki N, et al. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci USA. 2016;113(28):7858–63.
Rogers C, Fernandesalnemri T, Mayes L, Alnemri D, Cingolani G, Alnemri ES. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat Commun. 2017;8:1–14.
Kayagaki N, Stowe IB, Lee BL, O’Rourke K, Anderson K, Warming S, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526(7575):666–71.
Evavold CL, Ruan J, Tan Y, Xia S, Wu H, Kagan JC. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity. 2017;48(1):35–44.
Kayagaki N, Warming S, Lamkanfi M, Vande WL, Louie S, Dong J, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479(7371):117–21.
Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell. 1995;80(3):401–11.
Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell. 1998;92(4):501–9.
Petr B, Thomas R, Kamila B, Bouley DM, Nobuhiko K, Dixit VM, et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature. 2012;490(7419):288–91.
Rathinam VAK, Vanaja SK, Waggoner L, Sokolovska A, Becker C, Stuart LM, et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell. 2012;150(3):606–19.
Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature. 1997;368(6625):619–23.
Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 1995;267(5206):2000–3.
Chowdhury I, Tharakan B, Bhat GK. Caspases—an update. Comp Biochem Phys B. 2008;151(1):10–27.
Wang S, Miura M, Jung Y, Zhu H, Gagliardini V, Shi L, et al. Identification and characterization of Ich-3, a member of the interleukin-1beta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J Biol Chem. 1996;271(34):20580–7.
Faucheu C, Diu A, Chan AW, Blanchet AM, Miossec C, Hervé F, et al. A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J. 1995;14(9):1914–22.
Kamens J, Paskind M, Hugunin M, Talanian RV, Allen H, Banach D, et al. Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases. J Biol Chem. 1995;270(25):15250–6.
Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514(7521):187–92.
Case CL, Kohler LJ, Lima JB, Strowig T, de Zoete MR, Flavell RA, et al. Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila. Proc Natl Acad Sci USA. 2013;110(5):1851–6.
David C, Lalitha K, Tomaselli KJ, Spada AP, Wu JC. Structural and functional analysis of caspase active sites. Biochemistry. 2003;42(14):4151–60.
Walker NP, Talanian RV, Brady KD, Dang LC, Bump NJ, Ferenz CR, et al. Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer. Cell. 1994;78(2):343–52.
Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, et al. Structure and mechanism of interleukin-1 beta converting enzyme. Nature. 1994;370(6487):270–5.
Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature. 1992;356:768–74.
Casano FJ, Rolando AM, Mudgett JS, Molineaux SM. The Structure and complete nucleotide sequence of the murine gene encoding interleukin-1β converting enzyme (ICE). Genomics. 1994;20(3):474–81.
Shizuo A, Kiyoshi T. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499.
Mariathasan S. ASC, Ipaf and Cryopyrin/Nalp3: bona fide intracellular adapters of the caspase-1 inflammasome. Microbes Infect. 2007;9(5):664–71.
Bauernfeind FG, Horvath GA. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183(2):787–91.
Yuji K, Tamar S, Georgios V, Sosa MAG, Gregory E, Ozlem B, et al. A critical role for human caspase-4 in endotoxin sensitivity. J Immunol. 2014;193(1):335–43.
Rathinam VA, Vanaja SK, Fitzgerald KA. Regulation of inflammasome signaling. Nat Immunol. 2011;13(4):333–42.
Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science. 2013;341(6151):1250–3.
Vanaja SK, Russo AJ, Behl B, Banerjee I, Yankova M, Deshmukh SD, et al. Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation. Cell. 2016;165(5):1106–19.
Ellis TN, Kuehn MJ. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 2010;74(1):81–94.
Jäger J, Keese S, Roessle M, Steinert M, Schromm AB. Fusion of Legionella pneumophila outer membrane vesicles with eukaryotic membrane systems is a mechanism to deliver pathogen factors to host cell membranes. Cell Microbiol. 2015;17(5):607–20.
Meunier E, Dick MS, Dreier RF, Schürmann N, Kenzelmann BD, Warming S, et al. Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. Nature. 2014;509(7500):366–70.
Pilla DM, Hagar JA, Haldar AK, Mason AK, Daniel D, Klaus P, et al. Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. Proc Natl Acad Sci USA. 2014;111(16):6046–51.
Haldar AK, Saka HA, Piro AS, Dunn JD, Henry SC, Taylor GA, et al. IRG and GBP host resistance factors target aberrant, “non-self” vacuoles characterized by the missing of “self’’ IRGM proteins. PLoS Pathog. 2013;9(6):1–16.
Casson CN, Copenhaver AM, Zwack EE, Nguyen HT, Strowig T, Javdan B, et al. Caspase-11 activation in response to bacterial secretion systems that access the host cytosol. PLoS Pathog. 2013;9(6):1–16.
Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660–5.
Case CL. Regulating caspase-1 during infection: roles of NLRs, AIM2, and ASC. Yale J Biol Med. 2011;84(4):333–43.
Opal SM. Endotoxins and other sepsis triggers. Contrib Nephrol. 2010;167(167):14–24.
Moran AP, Prendergast MM, Appelmelk BJ. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. Pathog Dis. 1996;16(2):105–15.
Bi D, Wang Y, Gao Y, Li X, Chu Q, Cui J, et al. Recognition of lipopolysaccharide and activation of NF-κB by cytosolic sensor NOD1 in teleost fish. Front Immunol. 2018;9:1–15.
Pallett MA, Crepin VF, Serafini N, Habibzay M, Kotik O, Sanchez-Garrido J, et al. Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells. Mucosal Immunol. 2017;10(3):602–12.
Perera AP, Fernando R, Shinde T, Gundamaraju R, Southam B, Sohal SS, et al. MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice. Sci Rep. 2018;8(1):1–15.
All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Availability of data and materials
Consent for publication
All authors consent for publication.
Ethics approval and consent to participate
This research was supported by grants: Sichuan Agricultural Science and Technology Achievements Transformation Fund (No. 15NZ0008), Jiangsu Provincial Aquaculture Sanxin Project (No. D2017-4), and Applied Basic Research from Technological Office of Sichuan Province (No. 2015JY0206 and 19YYJC2725).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.